Eisai, Astellas Launch New Initiatives For Neglected Tropical Diseases For Corporate Responsibility And To Plant Seeds For New Markets
This article was originally published in PharmAsia News
Japanese pharmas’ interest in market expansion is leading companies to increase activity in global medicine access issues.
You may also be interested in...
Eisai Expands Relationship With Johns Hopkins For Neurological Disorders, Partnering Through "Open Innovation"
The US Department of Justice, SEC and the Chinese government have all increased investigations of corrupt practices, and incriminating evidence is easier than ever to find. What can companies do to protect themselves?
Astellas’ geographic and indication expansion strategy for Xtandi matches patent losses in Japan.